Achieve Life Sciences, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-10.6M | $-1.2M | $-828.0K | $-26.2M | $-31.8M | $-21.1M | $-14.7M | $-12.6M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $59.0K | $188.0K | $244.0K | $223.0K | $227.0K | $100.0K | $75.0K | $52.0K |
| Amortization | $200.0K | $200.0K | — | — | — | — | — | — |
| Stock-Based Compensation | $348.0K | $1.6M | $2.3M | $3.9M | $2.8M | $2.2M | $1.2M | $642.0K |
| Net Cash from Operating Activities | $-9.1M | $-202.0K | $-350.0K | $-17.3M | $-35.9M | $-43.5M | $-20.3M | $-26.8M |
| Investing Activities | ||||||||
| Capital Expenditures | — | $46.0K | $371.0K | $82.0K | $253.0K | $291.0K | $79.0K | $68.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $12.6M | — | — | — | $32.4M | $-21.2M | $25.1M | $-59.1M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $2.0M | $150.0K | — | — | $10.0K | $54.2M | $219.0K | $47.5M |
| Net Change in Cash | $5.5M | $-19.1M | $6.4M | $13.3M | $-3.5M | $-10.4M | $5.0M | $-38.5M |
| Free Cash Flow | — | $-248.0K | $-721.0K | $-17.4M | $-36.2M | $-43.8M | $-20.3M | $-26.9M |